Harbour Investments, Inc. Inovio Pharmaceuticals, Inc. Transaction History

Harbour Investments, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.79 - $1.91 $92 - $223	-117 Reduced 37.86%	192 $0
Q4 2022 Feb 15, 2023	BUY	$1.41 - $2.5 $164 - $292	117 Added 60.94%	309 $0
Q4 2021 Feb 16, 2022	SELL	$4.99 - $7.46 $32,674 - $48,848	-6,548 Reduced 97.15%	192 $1,000
Q3 2021 Nov 15, 2021	BUY	$7.16 - $9.69 $229 - $310	32 Added 0.48%	6,740 $48,000
Q2 2021 Aug 16, 2021	SELL	$6.23 - $10.03 $392 - $631	-63 Reduced 0.93%	6,708 $62,000
Q1 2021 Aug 17, 2021	BUY	$8.81 - $16.96 $59,502 - $114,547	6,754 Added 39729.41%	6,771 $63,000
Q1 2021 May 12, 2021	BUY	$8.81 - $16.96 $149 - $288	17 New	17 $0

281K

Ticker INO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 249,400,000
Market Cap $494M
Description
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...

Get notified when there are updates to the investment portfolio of Harbour Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Harbour Investments, Inc. with notifications on news.